Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial

Steven E. Nissen, Ricardo E. Dent-Acosta, Robert S. Rosenson, Erik S. Stroes, N. Sattar, David Preiss, G. B John Mancini, Christie M. Ballantyne, A. Catapano, Ioanna Gouni-Berthold, E. A. Stein, Allen Xue, Scott M. Wasserman, R. Scott, P. D. Thompson

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)137-144
Number of pages8
JournalClinical Cardiology
Issue number3
Publication statusPublished - 2016

Cite this